You searched for "cancers"
Management of the neck in maxillary sinus carcinomas
Primary malignant tumours of the sinonasal tract account for less than 10% of head and neck cancers, of which the maxilla is the second most common subsite and squamous cell carcinoma (SCC) is the most prevalent histological type. Maxillary SCCs...AAO-HNSF 2025 Annual Meeting & OTO EXPO
The global otolaryngology community reunites at the AAO-HNSF 2025 Annual Meeting & OTO EXPO in Indianapolis, Indiana, in October.Saturday morning starts with the Opening Ceremony, featuring James L Netterville, MD, as honorary guest lecturer for the John Conley MD Lecture...OBITUARY: Peter Rhys Evans (1948–2022)
On 3 June 2022, we lost a widely recognised and respected ENT/head and neck surgeon, Mr Peter Rhys Evans.Clinical leadership and management: developing world ENT
I have been asked to share some of the initiatives I have been involved with to address ENT-related challenges in Africa and the developing world. Developing countries constitute the majority of the world’s landmass (Figure 1), are home to >50%...Robotic surgery for squamous cell cancer: the new frontiers
Although the da Vinci platform was FDA approved for early-stage oropharyngeal cancers, the indications have expanded. In this article, John Hardman explains how surgeons, with greater understanding of the strengths and limitations of robotic surgery, have systematically set out to...In conversation with Professor Jatin Shah
We are honoured to welcome renowned head and neck surgeon, Professor Jatin Shah as Guest Editor of this edition of ENT and Audiology News. Here he speaks to Section Editor, Charlie Giddings, about his career, memorable achievements and advice for...Treatment regret in head and neck cancer – trading function for survival
Treatment for H&N cancer can be extremely tough for patients. How do we explain the likely impact as they try to make decisions? And what happens when they regret their choice? Treatment regret is a form of decision regret, involving...
